BridgeBio Oncology Therapeutics, Inc. (BBOT)
NASDAQ: BBOT · Real-Time Price · USD
2.620
-0.080 (-2.96%)
Oct 30, 2026, 4:00 PM EDT - Market closed
BBOT Market Cap
BBOT has a market cap or net worth of $210.06 million as of October 30, 2026. It is the 20,243rd most valuable company in the world and the 3,536th biggest in the United States. Its market cap has decreased by 77.08% in one year.
Market Cap
210.06M
Enterprise Value
-131.56M
1-Year Change
-77.08%
Global Rank
Country Rank
#3,536 United States
Category
ChartMarket Cap Chart
Since February 9, 2024, BBOT's market cap has increased from $38.21M to $210.06M, an increase of 449.71%. That is a compound annual growth rate of 86.97%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 30, 2026 | 210.06M | -79.02% |
| Dec 31, 2025 | 1.00B | 305.70% |
| Dec 31, 2024 | 246.84M | 545.98% |
| Feb 9, 2024 | 38.21M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Eledon Pharmaceuticals | 225.32M |
| Sol-Gel Technologies | 223.78M |
| AC Immune | 220.73M |
| Keros Therapeutics | 218.89M |
| Pyxis Oncology | 216.22M |
| Korro Bio | 210.80M |
| Protalix BioTherapeutics | 208.68M |
| Artiva Biotherapeutics | 204.85M |